For the Quarter Ending June 2026
Levodopa Prices in North America
- In USA, the Levodopa Price Index fell by 0.385% quarter-over-quarter, reflecting marginally softer import call-offs.
- The average Levodopa price for the quarter was approximately USD 41401.67/MT, reflecting freight-driven landed cost pressure.
- Steady Levodopa Spot Price liquidity limited upside despite elevated container freight and landed cost inflation.
- Levodopa Price Forecast indicates mild Q3 firming as buyers rebuild inventories and procurement resumes soon.
- Observed Levodopa Production Cost Trend shows rising freight and feedstock aromatics costs, offset by discounting.
- Broader Levodopa Demand Outlook remains steady due to Parkinsons therapy volumes and institutional procurement cycles.
- Measured Levodopa Price Index volatility reflected balanced imports from India and China and exporter discounting.
- Supply tightness at cGMP suites lengthened lead times, supporting CFR Los Angeles price resilience.
Why did the price of Levodopa change in June 2026 in North America?
- Rapid container freight escalation raised landed costs, though suppliers absorbed a portion of logistics premiums.
- Steady import availability from India and China maintained supply, reducing replenishment pressure on US formulators.
- Prescription volumes remained stable while generic competition and destocking tempered buyer willingness to accept offers.
Levodopa Prices in APAC
- In China, the Levodopa Price Index fell by 0.55% quarter-over-quarter, externally reflecting export-led downward pressure.
- The average Levodopa price for the quarter was approximately USD 41233.33/MT, reflecting balanced export activity.
- April environmental inspections tightened supply, supporting higher offers and firming the Levodopa Spot Price exports.
- The Levodopa Price Forecast suggests volatility as international restocking and seasonal procurement influence FOB offers.
- Higher coal and utility costs modestly influenced conversion economics and the Levodopa Production Cost Trend.
- Export purchases from regulated markets dominated shipments; the Levodopa Demand Outlook indicates steady restocking activity.
- Volume-based procurement capped domestic transfer prices, compressing margins and encouraging export-focused Levodopa Price Index support.
- Major producers maintained utilisation, allocating export cargoes and sustaining supply balance, limiting Levodopa price swings.
Why did the price of Levodopa change in June 2026 in APAC?
- Export-heavy shipments left buyers working through inventories, reducing immediate spot urgency and softening price momentum.
- Port congestion and vessel bunching increased transit delays and costs, weakening seller negotiating leverage materially.
- Balanced supply from integrated plants and compressed domestic margins under VBP limited Levodopa cost pass-through.
India
- In India, the Levodopa Price Index fell by 4.03% quarter-over-quarter, high runs and NPPA ceilings.
- Levodopa Spot Price weakened as recent Gujarat and Maharashtra output increased merchant stocks, easing pricing power.
Levodopa Prices in Europe
- In Germany, the Levodopa Price Index fell by 0.44% quarter-over-quarter, reflecting softer landed-cost offers from major exporters.
- The average Levodopa price for the quarter was approximately USD 41376.67/MT under CFR Hamburg terms, reflecting inventory adjustments.
- Improved origin-side offers compressed the Levodopa Spot Price while the Levodopa Price Index remained marginally soft.
- Rising energy surcharges in India and Spain influenced the Levodopa Production Cost Trend, sustaining modest cost-push pressure.
- Levodopa Demand Outlook shows steady inelastic consumption from Parkinsons therapies, limiting downside despite spot supply improvements.
- Near-term Levodopa Price Forecast indicates minor oscillations as restocking and seasonal tendering offset origin-based supply shifts.
- Extended transit times and Rhine low-water added logistics premiums, pressuring landed costs and shortening distributor inventory cover.
- Indian and European CDMOs shifted capacity toward higher-margin intermediates, reducing export allotments and tightening prompt availability.
Why did the price of Levodopa change in June 2026 in Europe?
- Larger-volume offers from India and Spain reduced landed costs, creating downward pressure on June CFR Hamburg pricing.
- Stable domestic demand for Parkinsons therapies left limited absorption capacity, restraining price recovery despite tight earlier supply.
- Logistics normalisation at Hamburg ports and eased spot availability shortened lead times, relieving immediate upward price pressures.
For the Quarter Ending March 2026
Levodopa Prices in APAC
- In China, the Levodopa Price Index fell by 7.06% quarter-over-quarter, driven by softer export bookings.
- The average Levodopa price for the quarter was approximately USD 41463.33/MT, reflecting balanced export demand.
- Levodopa Spot Price tightened after two coastal catechol lines curtailed, trimming export parcels, tightening availability.
- Levodopa Price Forecast anticipates modest near-term upside as buyers restock amid constrained spot supply cautiously.
- Levodopa Production Cost Trend stayed flat as L-tyrosine supply and power tariffs kept costs steady.
- Levodopa Demand Outlook strengthened as North American and European formulators accelerated procurement to diversify sourcing.
- Levodopa Price Index improved month-on-month in March as inventories fell and operating rates eased slightly.
- Exporters maintained disciplined shipments while Levodopa Spot Price reacted to freight and port logistics constraints.
Why did the price of Levodopa change in March 2026 in APAC?
- Coastal catechol unit curtailments removed roughly 150 tonnes, tightening export availability and reducing warehouse cover.
- Orders from US and European formulators accelerated, increasing export demand and lifting FOB Shanghai offers.
- Stable feedstock and unchanged power tariffs limited cost pressure, so price rise reflected supply-demand imbalance.
Levodopa Prices in Europe
- In Germany, the Levodopa Price Index fell by 7.03% quarter-over-quarter, reflecting constrained margins and pressures.
- The average Levodopa price for the quarter was approximately USD 41560/MT, reflecting trading activity patterns.
- Levodopa Spot Price firmed on tighter availability as Rhine low-water and logistics surcharges constrained supply.
- Levodopa Price Forecast points to modest near-term gains driven by replenishment buying and pharmaceutical procurement.
- Levodopa Production Cost Trend flat as feedstock and energy costs showed limited movement across origins.
- Levodopa Demand Outlook stays steady, anchored in inelastic Parkinsons therapy demand and routine tender-driven procurement.
- Levodopa Price Index volatility limited as imports from India, Spain, and Italy maintained inventory cushions.
- Major origin plants reported operations, while export flows and competitive offers constrained German spot availability.
Why did the price of Levodopa change in March 2026 in Europe?
- Rhine low-water increased inland trucking and handling costs, temporarily tightening prompt availability and pushing landed costs.
- Steady pharmaceutical demand and thin formulators inventories encouraged importers to accept premiums, supporting modest price uptick.
- Stable feedstock and energy costs restrained upward pressure, while freight surcharges and Euro stability supported prices.
Levodopa Prices in North America
- In the USA, the Levodopa Price Index fell by 7.03% quarter-over-quarter, prompting negotiation among generic formulators.
- The average Levodopa price for the quarter was approximately USD 41,561.67/MT, reflecting CFR Los Angeles dynamics.
- Levodopa Spot Price softened as freight rose and spot availability tightened, lifting CFR landed costs.
- Levodopa Price Forecast shows modest near-term strengthening amid logistic pressure and selective restocking by formulators.
- Levodopa Production Cost Trend highlighted higher freight and bunker surcharges, raising delivered costs for US importers.
- Levodopa Demand Outlook remained stable with steady prescriptions yet increased buyer price sensitivity and negotiation.
- Levodopa Price Index movements reflected container freight swings and resilient export supply from India and China.
- Spot offers from exporters contained volatility while Levodopa Spot Price stayed consistently aligned with contract quotations.
Why did the price of Levodopa change in March 2026 in North America?
- Higher Shanghai-to-Houston container freight increased landed costs, transmitting upward pressure to CFR Levodopa quotations domestically.
- Pharmacy shortages and intensified hospital procurement accelerated buying, tightening spot availability and supporting price firmness.
- Export manufacturing steady but elevated bunker surcharges and logistics transmitted higher delivered costs to importers.
For the Quarter Ending December 2025
North America
- In USA, the Levodopa Price Index rose by 1.82% quarter-over-quarter, due to freight, cautious restocking.
- The average Levodopa price for the quarter was approximately USD 63351.67/MT, CFR Los Angeles tallies.
- Levodopa Price Index showed monthly gains as freight declines partially offset steady pharmaceutical offtake levels.
- Levodopa Spot Price remained firm as buyers preferred replacement purchases amid normalized imports and logistics.
- Levodopa Production Cost Trend stayed stable with feedstock prices steady and manufacturers maintaining consistent output.
- Levodopa Demand Outlook remained constructive as ageing demographics and clinical activity supported steady prescription volumes.
- Levodopa Price Forecast indicates modest controlled increases as freight normalizes and buyers rebuild limited inventories.
- Inventory comfort and measured export demand left sellers disciplined, keeping upward price movements moderate only.
Why did the price of Levodopa change in December 2025 in North America?
- Lower ocean freight in December reduced landed costs, offsetting firm pharmaceutical demand, yielding near-flat net movement.
- Elevated earlier freight surcharges and cautious seller offers sustained upward pressure despite comfortable global inventories.
- Buyers rebuilding lean stocks and ongoing clinical demand supported procurement, preventing price declines in December.
APAC
- In China, the Levodopa Price Index rose by 1.85% quarter-over-quarter, driven by firm export demand and tighter inventories.
- The average Levodopa price for the quarter was approximately USD 63266.67/MT, reflecting tightened export procurement.
- Levodopa Spot Price recorded marginal gains as buyers advanced purchases ahead of year-end formulation campaigns.
- Levodopa Price Forecast shows mild upside as steady demand and higher freight maintain price discipline.
- Levodopa Production Cost Trend reflects elevated air freight and compliance costs pressuring producer margins modestly.
- Levodopa Demand Outlook remains constructive due to Parkinsons therapy output and export restocking by formulators.
- Levodopa Price Index stayed firm as inventories tightened and selective forward buying reinforced seller confidence.
- Major Chinese plants maintained routine output; port efficiency improved though seasonal logistics slowdowns persisted modestly.
Why did the price of Levodopa change in December 2025 in APAC?
- Supply constraints from earlier flooding and intermittent downtime tightened availability and supported FOB price increases.
- Elevated air-freight and port fees raised logistics costs, prompting suppliers to pass higher FOB values.
- Firm export demand and forward buying amid tightening inventories sustained upward pricing momentum during December.
Europe
- In Germany, the Levodopa Price Index rose by 1.80% quarter-over-quarter, reflecting constrained supply and logistics.
- The average Levodopa price for the quarter was approximately USD 63345.00/MT, reflecting CFR Hamburg costs.
- Levodopa Spot Price stayed firm as buyers restocked ahead of holidays, limiting downward price pressure.
- Levodopa Price Forecast indicates modest gains from freight and exchange-rate effects, followed by early-year correction.
- Levodopa Production Cost Trend shows upward pressure from energy and compliance costs, supporting landed prices.
- Levodopa Demand Outlook remains steady with ageing population-driven offtake and low price elasticity supporting purchases.
- Levodopa Price Index was amplified by precautionary restocking and limited export reallocations from constrained suppliers.
- Major supplier operations were broadly normal, keeping inventories adequate and capping Levodopa Price Index spikes.
Why did the price of Levodopa change in December 2025 in Europe?
- Constrained API exports and selective Indian allotments reduced available cargoes, tightening spot availability and lifting landed costs.
- Precautionary German restocking and hospital forward buying increased near-term demand, outweighing otherwise stable monthly volumes.
- Elevated freight and port-related surcharges plus modest currency weakness amplified CIF prices despite orderly import arrivals.
For the Quarter Ending September 2025
North America
- In the USA, the Levodopa Price Index fell by 1.19% quarter-over-quarter, Q3 2025, due to destocking.
- The average Levodopa price for the quarter was approximately USD 62216.67/MT, weighted by Los Angeles volumes.
- Levodopa Spot Price remained pressured through the quarter amid logistical corrections and subdued booking activity.
- Levodopa Price Forecast indicates modest stabilization with upward bias as restocking emerges and imports normalize.
- Levodopa Production Cost Trend was stable; freight cost correction reduced landed cost pressure during the quarter.
- Levodopa Demand Outlook remains tepid with cautious pharmacy buying and seasonal uptick failing to materialize.
- Levodopa Price Index sensitivity increased as strategic stockpiling earlier in quarter then accelerated inventory liquidation.
- Market participants noted balanced import volumes and disciplined selling, constraining volatility while margins slightly adjusted.
Why did the price of Levodopa change in September 2025 in North America?
- Destocking and earlier strategic stockpiles reduced immediate purchasing, weakening demand and further pressuring mid-quarter prices.
- Ocean freight corrections and easing logistics lowered landed costs, translating into reduced upward price momentum.
- Uncertain trade policy and tariff threats provoked frontloading earlier, then softened bookings causing price moderation.
APAC
- In China, the Levodopa Price Index fell by 1.2% quarter-over-quarter, reflecting weak export demand and inventories.
- The average Levodopa price for the quarter was approximately USD 62116.67/MT, reflecting subdued export and domestic purchasing activity.
- Levodopa Price Forecast points to mild recovery as shipping costs rise and producers manage production schedules.
- Levodopa Production Cost Trend showed easing input prices but episodic weather disruptions increased operational expenses for some manufacturers.
- Levodopa Demand Outlook remains cautious with western buyers restocking selectively while overall consumption stays subdued.
- Levodopa Price Index and Spot Price volatility reflected inventory accumulation, competitive export pricing, and seasonal procurement ahead.
- Rising unsold inventories pressured margins while strategic export demand spurts produced short-lived upward price adjustments.
- Major Chinese producers operated steady utilization, adapting offers and flexible volumes to stimulate offtake amid soft markets.
Why did the price of Levodopa change in September 2025 in APAC?
- Weak international demand reduced buying urgency and increased competition among exporters, pressuring export FOB prices.
- Lower logistics costs and abundant shipping capacity gave purchasers leverage, contributing to downward price pressure.
- Domestic overcapacity and accumulating inventories forced sellers into flexible pricing strategies to maintain order flow.
Europe
- In Germany, the Levodopa Price Index fell by 1.1129% quarter-over-quarter, reflecting surplus inventories and conservative purchasing.
- The average Levodopa price for the quarter was approximately USD 62223.67/MT, landed costs and logistics adjustments.
- Levodopa Spot Price remained pressured by elevated stock levels and muted spot buying across distributors and wholesalers.
- Levodopa Price Forecast indicates upward adjustments as Q3 restocking and logistical costs normalize, challenging tolerance levels.
- Levodopa Production Cost Trend showed limited inflationary feedstock impact, with freight delays influencing landed costs and margins.
- Levodopa Demand Outlook remains cautious; hospital and distributor buying disciplined, avoiding speculative inventory accumulation across channels.
- Levodopa Price Index movements were influenced by port congestion, delayed freight surcharges, and deferred procurement behavior patterns.
- Major supplier operational status was stable, enabling balanced imports despite transport bottlenecks and seasonal surcharges affecting timings.
Why did the price of Levodopa change in September 2025 in Europe?
- Elevated inventories and deliberate destocking reduced buying urgency, easing price pressures in the market effectively.
- Logistics disruptions and delayed freight surcharges temporarily increased landed cost uncertainty, prompting cautious purchasing decisions.
- Steady end-user demand matched improved incoming shipments, limiting spot tightness and restraining further price escalation.
